Results 21 to 30 of about 67 (63)
Antiviral activities of sotrovimab against BQ.1.1 and XBB.1.5 in sera of treated patients
, 2023 Bruel T, Vrignaud L, Porrot F, Staropoli I, Planas D, Guivel-Benhassine F, Puech J, Prot M, Munier S, Henry-Bolland W, Soulié C, Zafilaza K, Lusivika-Nzinga C, Meledge M, Dorival C, Molino D, Péré H, Yordanov Y, Simon-Lorière E, Veyer D, Carrat F, Schwartz O, Marcelin A, Martin-Blondel G, the ANRS 0003S CoCoPrev Study Group. +24 moreeuropepmc +1 more sourceClinical Phenotypes of Critically Ill Patients with COVID-19 Infected with Omicron: A Nationwide Prospective Cohort Study. [PDF]
Infect Dis TherAudureau E, Bay P, Préau S, Favory R, Guigon A, Heming N, Gault E, Pham T, Chaghouri A, Turpin M, Morand-Joubert L, Jochmans S, Pitsch A, Meireles S, Contou D, Henry A, Roux D, Le Hingrat Q, Kimmoun A, Hartard C, Pène F, L'Honneur AS, Guillon A, Handala L, Tamion F, Moisan A, Daix T, Hantz S, Delamaire F, Thibault V, Darreau C, Thomin J, Pawlotsky JM, Fourati S, de Prost N, SEVARVIR investigators. +35 moreeuropepmc +1 more sourceClinical phenotypes and outcomes associated with SARS-CoV-2 Omicron sublineage JN.1 in critically ill COVID-19 patients: a prospective, multicenter cohort study in France, November 2022 to January 2024. [PDF]
Ann Intensive Carede Prost N, Audureau E, Guillon A, Handala L, Préau S, Guigon A, Uhel F, Le Hingrat Q, Delamaire F, Grolhier C, Tamion F, Moisan A, Darreau C, Thomin J, Contou D, Henry A, Daix T, Hantz S, Saccheri C, Giordanengo V, Pham T, Chaghouri A, Bay P, Pawlotsky JM, Fourati S, SEVARVIR investigators. +25 moreeuropepmc +1 more sourceCorrection: COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants. [PDF]
Ann Intensive CareBay P, Audureau E, Préau S, Favory R, Guigon A, Heming N, Gault E, Pham T, Chaghouri A, Turpin M, Morand-Joubert L, Jochmans S, Pitsch A, Meireles S, Contou D, Henry A, Joseph A, Chaix ML, Uhel F, Roux D, Descamps D, Emery M, Garcia-Sanchez C, Levy D, Burrel S, Mayaux J, Kimmoun A, Hartard C, Pène F, Rozenberg F, Gaudry S, Brichler S, Guillon A, Handala L, Tamion F, Moisan A, Daix T, Hantz S, Delamaire F, Thibault V, Souweine B, Henquell C, Picard L, Botterel F, Rodriguez C, Dessap AM, Pawlotsky JM, Fourati S, de Prost N, SEVARVIR investigators. +49 moreeuropepmc +1 more sourceCOVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants. [PDF]
Ann Intensive CareBay P, Audureau E, Préau S, Favory R, Guigon A, Heming N, Gault E, Pham T, Chaghouri A, Turpin M, Morand-Joubert L, Jochmans S, Pitsch A, Meireles S, Contou D, Henry A, Joseph A, Chaix ML, Uhel F, Roux D, Descamps D, Emery M, Garcia-Sanchez C, Levy D, Burrel S, Mayaux J, Kimmoun A, Hartard C, Pène F, Rozenberg F, Gaudry S, Brichler S, Guillon A, Handala L, Tamion F, Moisan A, Daix T, Hantz S, Delamaire F, Thibault V, Souweine B, Henquell C, Picard L, Botterel F, Rodriguez C, Mekontso Dessap A, Pawlotsky JM, Fourati S, de Prost N, SEVARVIR investigators. +49 moreeuropepmc +1 more sourceViral clearance and escape during therapy of COVID-19 outpatients: A prospective cohort study. [PDF]
iScienceMartin-Blondel G, Burgat P, Leducq V, Porrot F, Cottignies-Calamarte A, De Cruz A, Dorival C, Romieu-Mourez R, Chaubet C, Cazaentre V, Boumaza X, Richier Q, Gaborit B, Coustilleres F, Dubée V, Ader F, Yordanov Y, Schwartz O, Marcelin AG, Lusivika-Nzinga C, Carrat F, Soulié C, Liblau R, Bruel T, ANRS 0003S CoCoPrev Study Group. +24 moreeuropepmc +1 more sourceScreening methods for thyroid hormone disruptors. [PDF]
Environ Health Perspect, 1999 DeVito M, Biegel L, Brouwer A, Brown S, Brucker-Davis F, Cheek AO, Christensen R, Colborn T, Cooke P, Crissman J, Crofton K, Doerge D, Gray E, Hauser P, Hurley P, Kohn M, Lazar J, McMaster S, McClain M, McConnell E, Meier C, Miller R, Tietge J, Tyl R. +23 moreeuropepmc +1 more source
